Reported Consolidated quarterly numbers for Panacea Biotec are:
Net Sales at Rs 115.72 crore in June 2024 down 10.43% from Rs. 129.19 crore in June 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 15.80 crore in June 2024 down 243.9% from Rs. 10.98 crore in June 2023.
EBITDA stands negative at Rs. 10.19 crore in June 2024 down 140.9% from Rs. 4.23 crore in June 2023.
Panacea Biotec shares closed at 238.75 on August 26, 2024 (NSE) and has given 45.85% returns over the last 6 months and 72.57% over the last 12 months.
Story continues below Advertisement
| Panacea Biotec | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 115.72 | 136.46 | 129.19 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 115.72 | 136.46 | 129.19 | | EXPENDITURE | | Consumption of Raw Materials | 40.24 | 45.53 | 57.32 | | Purchase of Traded Goods | -- | -0.49 | 1.20 | | Increase/Decrease in Stocks | 1.48 | 4.71 | -3.66 | | Power & Fuel | -- | -- | -- | | Employees Cost | 37.50 | 38.43 | 35.97 | | Depreciation | 8.73 | 8.81 | 9.48 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 50.49 | 54.32 | 48.67 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -22.72 | -14.85 | -19.79 | | Other Income | 3.80 | 10.81 | 6.08 | | P/L Before Int., Excpt. Items & Tax | -18.92 | -4.04 | -13.71 | | Interest | 0.87 | 0.82 | 1.00 | | P/L Before Exceptional Items & Tax | -19.79 | -4.86 | -14.71 | | Exceptional Items | 2.74 | 2.74 | 27.74 | | P/L Before Tax | -17.05 | -2.12 | 13.03 | | Tax | -1.17 | -0.13 | 2.05 | | P/L After Tax from Ordinary Activities | -15.88 | -1.99 | 10.98 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -15.88 | -1.99 | 10.98 | | Minority Interest | 0.08 | 0.56 | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -15.80 | -1.43 | 10.98 | | Equity Share Capital | 6.13 | 6.13 | 6.13 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.59 | -0.23 | 1.79 | | Diluted EPS | -2.59 | -0.23 | 1.79 | | EPS After Extra Ordinary | | Basic EPS | -2.59 | -0.23 | 1.79 | | Diluted EPS | -2.59 | -0.23 | 1.79 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
